See more : Globalink Investment Inc. (GLLIW) Income Statement Analysis – Financial Results
Complete financial analysis of PAO Group, Inc. (PAOG) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of PAO Group, Inc., a leading company in the Medical – Care Facilities industry within the Healthcare sector.
- Radiant Opto-Electronics Corporation (6176.TW) Income Statement Analysis – Financial Results
- On Holding AG (ONON) Income Statement Analysis – Financial Results
- Ingersoll-Rand (India) Limited (INGERRAND.BO) Income Statement Analysis – Financial Results
- Twilio Inc. (TWLO) Income Statement Analysis – Financial Results
- National Fittings Limited (NATFIT.BO) Income Statement Analysis – Financial Results
PAO Group, Inc. (PAOG)
About PAO Group, Inc.
PAO Group, Inc. focuses on alternative patient care treatments. The company, through its subsidiaries, engages in the development, sale, and distribution of premium medical cannabis products for treatment of chronic and terminal patients. The company is headquartered in Sandusky, Ohio.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 287.82K |
Cost of Revenue | 0.00 | 2.74K | 1.80K | 0.00 | 0.00 | 250.12K |
Gross Profit | 0.00 | -2.74K | -1.80K | 0.00 | 0.00 | 37.70K |
Gross Profit Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 13.10% |
Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
General & Administrative | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
SG&A | 45.42K | 185.81K | 340.32K | 14.31K | 72.86K | 244.43K |
Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | -4.13K | 0.00 |
Operating Expenses | 45.42K | 185.81K | 340.32K | 14.31K | 76.99K | 244.43K |
Cost & Expenses | 45.42K | 188.55K | 342.12K | 14.31K | 76.98K | 494.55K |
Interest Income | 0.00 | 0.00 | 97.53K | 0.00 | 0.00 | 0.00 |
Interest Expense | 57.46K | 62.61K | 55.72K | 35.89K | 58.53K | 103.76K |
Depreciation & Amortization | 167.90K | 228.49K | 236.56K | 206.30K | 171.86K | 161.14K |
EBITDA | 292.96K | -188.55K | -244.59K | -14.31K | 1.20M | -206.73K |
EBITDA Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -71.83% |
Operating Income | -45.42K | -188.55K | -342.12K | -14.31K | -76.99K | -206.73K |
Operating Income Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -71.83% |
Total Other Income/Expenses | 280.93K | -62.61K | 41.81K | -37.24K | 1.22M | -103.76K |
Income Before Tax | 235.51K | -251.16K | -300.30K | -51.55K | 1.14M | -310.49K |
Income Before Tax Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -107.88% |
Income Tax Expense | -167.90K | -228.49K | -236.56K | -206.30K | -171.86K | -161.14K |
Net Income | 235.51K | -251.16K | -300.30K | -51.55K | 1.14M | -310.49K |
Net Income Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -107.88% |
EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Weighted Avg Shares Out | 1.91B | 1.91B | 1.91B | 1.40B | 914.18M | 815.18M |
Weighted Avg Shares Out (Dil) | 1.91B | 1.91B | 1.91B | 1.40B | 914.18M | 815.18M |
PAOG Confirms $300,000 Sales Agreement with Cannabis Cultivation Subsidiary
PAOG Confirms $300,000 Sales Agreement with Cannabis Cultivation Subsidiary
PAOG Confirms CBD Nutraceutical Development And Distribution Partners
PAOG Confirms CBD Nutraceutical Development and Distribution Partners
PURA and USMJ Enter Strategic Negotiations
Green Stream Holdings Prepares for Major 2021 Growth with Appointment of New CEO James C. DiPrima
PAOG To Distribute CBD Nutraceuticals Through USMJ Ecommerce Site
PURA in Partnership with PAOG and ALKM Prepare for Biden Bull Cannabis Market
PURA in Partnership with PAOG and ALKM Prepare for Biden Bull Cannabis Market
PAOG Publishes 2021 Cannabis Biopharmaceutical Strategic Outlook
Source: https://incomestatements.info
Category: Stock Reports